Toxoplasmosis of the bladder in a patient with AIDS.
Besnier
J M
JM
Verdier
M
M
Cotty
F
F
Fétissof
F
F
Besancenez
A
A
Choutet
P
P
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000469:parasitology*; D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000913:Antibodies, Protozoan / Q000032:analysis; D001706:Biopsy; D002981:Clindamycin / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D008297:Male; D008875:Middle Aged; D011739:Pyrimethamine / Q000627:therapeutic use; D014122:Toxoplasma / Q000276:immunology; D014123:Toxoplasmosis / Q000188:drug therapy / Q000209:etiology*; D001743:Urinary Bladder / Q000469:parasitology / Q000473:pathology; D001745:Urinary Bladder Diseases / Q000188:drug therapy / Q000469:parasitology*
D000890:Anti-Infective Agents; D000913:Antibodies, Protozoan; D002981:Clindamycin; D011739:Pyrimethamine